These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35999229)

  • 1. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.
    Mendoza TR; Hong DS; Peterson CB; Stephen B; Dumbrava E; Pant S; Tsimberidou AM; Yap TA; Sheshadri A; Altan M; George G; Castillo L; Rodriguez E; Gong J; Subbiah V; Janku F; Fu S; Piha-Paul SA; Ahnert JR; Karp DD; Cleeland C; Meric-Bernstam F; Naing A
    Sci Rep; 2022 Aug; 12(1):14367. PubMed ID: 35999229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms in the general Norwegian adult population - prevalence and associated factors.
    Krogstad H; Loge JH; Grotmol KS; Kaasa S; Kiserud CE; Salvesen Ø; Hjermstad MJ
    BMC Public Health; 2020 Jun; 20(1):988. PubMed ID: 32576168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer.
    Kamal M; Wang XS; Shi Q; Mendoza T; Garcia-Gonzalez A; Bokhari RH; Cleeland CS; Fogelman DR
    J Pain Symptom Manage; 2020 May; 59(5):1052-1058.e1. PubMed ID: 31982605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
    George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
    Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
    Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
    J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study.
    Deng Y; Hu H; Jia R; Dai W; Wang D; Zhang P; Zhang P; Cheng K; Tang J; Wen Y; Zhou X; Shi Q; Xiong Z; Zhou J
    BMC Pulm Med; 2023 May; 23(1):176. PubMed ID: 37208661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
    Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS
    Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma.
    Cleeland CS; Keating KN; Cuffel B; Elbi C; Siegel JM; Gerlinger C; Symonds T; Sloan JA; Dueck AC; Bottomley A; Wang XS; Williams LA; Mendoza TR
    Sci Rep; 2024 Jun; 14(1):14839. PubMed ID: 38937473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Symptom Burden Among Cancer Patients With Different Stages of Cachexia.
    Zhou T; Yang K; Thapa S; Liu H; Wang B; Yu S
    J Pain Symptom Manage; 2017 May; 53(5):919-926. PubMed ID: 28062340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
    Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
    Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
    Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
    J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.
    Mendoza T; Sheshadri A; Altan M; Hess K; George G; Stephen B; Castillo L; Rodriguez E; Gong J; Peterson C; Rodon Ahnert J; Fu S; Piha-Paul SA; Pant S; Dumbrava E; Yap TA; Janku F; Tsimberidou AM; Subbiah V; Karp DD; Zarifa A; McQuinn LM; Cleeland C; Hong DS; Naing A
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33097611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.
    Cleeland CS; Zhao F; Chang VT; Sloan JA; O'Mara AM; Gilman PB; Weiss M; Mendoza TR; Lee JW; Fisch MJ
    Cancer; 2013 Dec; 119(24):4333-40. PubMed ID: 24114037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial.
    Wang XS; Rhines LD; Shiu AS; Yang JN; Selek U; Gning I; Liu P; Allen PK; Azeem SS; Brown PD; Sharp HJ; Weksberg DC; Cleeland CS; Chang EL
    Lancet Oncol; 2012 Apr; 13(4):395-402. PubMed ID: 22285199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
    Pal SK; McDermott DF; Atkins MB; Escudier B; Rini BI; Motzer RJ; Fong L; Joseph RW; Oudard S; Ravaud A; Bracarda S; Suárez C; Lam ET; Choueiri TK; Ding B; Quach C; Hashimoto K; Schiff C; Piault-Louis E; Powles T
    BJU Int; 2020 Jul; 126(1):73-82. PubMed ID: 32233107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
    Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
    Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study.
    Mendoza TR; Kehl KL; Bamidele O; Williams LA; Shi Q; Cleeland CS; Simon G
    Support Care Cancer; 2019 Sep; 27(9):3439-3447. PubMed ID: 30661202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.